Programmable Bio

Strategy

Build-vs-partner, three-phase go-to-market, North Star metric, and the risk plan including the agentic-lab interface controls.

Build vs Partner →

The FAL decision: why we don't own robots in Phase 1.

Go-to-Market →

Three-phase sequence: Apollo anchor → APAC bridge → Series B.

North Star & KPIs →

Closed-loop discovery cycles per quarter and full KPI grid.

Risks & Mitigation →

Enterprise risks plus the dedicated agentic-lab interface risk plan.